Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Merck & Co Inc MRK

Healthcare
Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for... see more

Recent & Breaking News (NYSE:MRK)

StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX

Accesswire May 15, 2013

The Real Story Behind NTAP, SNV and MRK

Marketwired May 14, 2013

Merck to Present at the Bank of America/Merrill Lynch 2013 Healthcare Conference

Business Wire May 14, 2013

Special Situation Coming Soon, a Look Inside DDD, JNJ, MRK and EXC

Marketwired May 11, 2013

The Straight Truth, Investing in RAX and MRK

Marketwired May 10, 2013

Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc.

PR Newswire May 9, 2013

GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck's HPV Vaccine, Available to Developing Countries through UNICEF Tender

Business Wire May 9, 2013

Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet

Business Wire May 8, 2013

Before the Crowd, How We Found EOG, IBM, YHOO and MRK

Marketwired May 8, 2013

The Straight Truth, Investing in GE, MRK, LINE and LNKD

Marketwired May 7, 2013

Merck and Celebrity Chef Art Smith "Cook Up a Recipe" for Better Type 2 Diabetes Management

PR Newswire May 7, 2013

Merck Consumer Care Launches Health and Wellness Effort To Help Empower Moms To Live A More Active Lifestyle With Their Families

PR Newswire May 6, 2013

FDA Approves Merck's LIPTRUZET(TM) (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol

Business Wire May 3, 2013

Perfect Trade Setups, How to Play AAPL, MRK, AGN and MSFT

Marketwired May 2, 2013

Free Research Reports on CREE, HCA, MRK and ROP Issued by the Paragon Report

Marketwired May 1, 2013

Merck Announces First-Quarter 2013 Financial Results

Business Wire May 1, 2013

Merck Announces New $15 Billion Share Repurchase Program

Business Wire May 1, 2013

Merck Wins FOSAMAX® (alendronate sodium) Federal Bellwether Trial Involving Atypical Femur Fracture Claims

Business Wire April 29, 2013

Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes

Business Wire April 29, 2013

Key to Success, How to Profit: BIDU, MRK, CTXS and S

Marketwired April 26, 2013